Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Tyrosine kinase receptors
Sep 24, 2018
Okayama University Research: Insights Into Mechanisms Governing the Resistance to the Anti-Cancer Medication Cetuximab
Sep 13, 2018
Positive Clinical Trial and R&D Developments Creating Big Opportunities and Big Returns for Biotech Industry
Sep 06, 2018
Merrimack Completes Enrollment in Randomized Phase 2 SHERLOC Study of MM-121 (seribantumab) in Non-Small Cell Lung Cancer (NSCLC)
Sep 05, 2018
BerGenBio to Present Interim Phase 2 Clinical Data With Selective AXL Inhibitor Bemcentinib in Non-small Cell Lung Cancer at WCLC
Aug 29, 2018
The Bonnie J. Addario Lung Cancer Foundation Joins Forces with Patient Advocate Group to Advance Care for People with EGFR-Positive Lung Cancer
Jun 28, 2018
BioAtla Announces First Patient Treated In Phase1/2 BA3021-001 Clinical Trial For CAB-ROR2-ADC Therapeutic
Jun 22, 2018
ALK and ROS1 Clones from CST Featured in Latest Guidelines for the Diagnosis and Treatment of Non-Small Cell Lung Cancer
Jun 03, 2018
BerGenBio Provides Interim Update on Phase II Clinical Programme With Selective Oral AXL Inhibitor Bemcentinib
Jun 01, 2018
Daiichi Sankyo Presents Preliminary Phase 1 Data for Antibody Drug Conjugate U3-1402 in Patients with HER3-Expressing Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 29, 2018
FDA Accepts Larotrectinib New Drug Application and Grants Priority Review
May 18, 2018
BerGenBio to Present Interim Clinical and Biomarker Data With Selective AXL Inhibitor Bemcentinib in AML and MDS at EHA
May 01, 2018
Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for Patient Diagnosed with Non-Small Cell Lung Cancer
Apr 15, 2018
Blueprint Medicines Publication in Cancer Discovery Highlights Preclinical and Clinical Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667
Apr 13, 2018
Menarini Ricerche to Present the Most Recent Pre-clinical Data About the PI3K Inhibitor MEN1611 at the AACR Annual Meeting 2018
Apr 13, 2018
Promising Pre-clinical Data Supporting BerGenBio's Pipeline to be Published and Presented at Upcoming Leading Conferences
Apr 10, 2018
BerGenBio Completes Recruitment Into First Stage of Phase II NSCLC Trial With Selective AXL Inhibitor Bemcentinib Combined With KEYTRUDA®
Apr 09, 2018
Amgen To Present New Pre-Clinical Data Showcasing Robust Approach To Evaluating Potential Anti-Cancer Therapies At AACR 2018
Mar 26, 2018
Bayer Announces Completion of Rolling Submission of New Drug Application in the U.S. for Larotrectinib for the Treatment of TRK Fusion Cancer
Feb 28, 2018
BioAtla Announces First Patient Treated In Phase1/2 BA3011-001 Clinical Trial For CAB-AXL-ADC Therapeutic
Feb 26, 2018
Proto Oncogene Market & Clinical Pipeline Insight 2024
‹‹
Page 5
››
Latest News
Mar 28, 2024
Slip Robotics Wins Best New Innovation in the Supply Chain at MODEX 2024
Mar 28, 2024
South Africa Motor Vehicle Industry Report 2023: Muted Domestic Sales and Export Slowdown Propose Challenges...
Mar 28, 2024
Gresham Worldwide, Inc. Announces New Head of Israeli Defense Subsidiary
Mar 28, 2024
Solace Capital Partners Provides Growth Capital to Siprocal
Mar 28, 2024
Cognyte to Announce Fourth Quarter and Full Year FY2024 Financial Results on April 9, 2024
Mar 28, 2024
Iveda Finds 84% of Americans Are Concerned About Violence in The Country; Many Believe AI Could Help
Mar 28, 2024
Voltera Welcomes Marie Robinson to Its Board of Directors
Mar 28, 2024
Former Army Maj. Gen. John B. Richardson IV Joins USAA To Lead Military Affairs
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events